Please login to the form below

Not currently logged in
Email:
Password:

Medius Deal Watch

This page shows the latest Medius Deal Watch news and features for those working in and with pharma, biotech and healthcare.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    Deal Watch March 2017. Sanofi, MedImmune, AstraZeneca, Astellas, Novartis and more feature in this month's pharma deals round-up. ... Each month the Deal Watch team ploughs our merry way through the details of 600 plus deals to bring you the edited

  • Deal Watch February 2017 Deal Watch February 2017

    Deal Watch February 2017. Actelion, Johnson &Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up. ... The deal also includes a licence to AKB-5169 (formerly JNJ5169), an oral, preclinical stage compound for inflammatory bowel

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    On reviewing the data captured in its monthly Deal Watch reviews Medius said a significant downturn in deal activity was evident. ... This article was based on Medius' Annual Review of its Deal Watch service.

  • Deal Watch January 2017 Deal Watch January 2017

    Deal Watch January 2017. Actelion, Johnson &Johnson, Sanofi, Takeda and more feature in this month's pharma deals round-up. ... Deal Watch table spending its overseas dollars on the acquisition of Actelion for an all cash deal of $30bn (30 times price to

  • Deal Watch December 2016 Deal Watch December 2016

    Deal Watch December 2016. Allergan, AZ, BMS, Pfizer, Roche and more feature in this month's pharma deals round-up. ... Behind the headlines of these early stage deals it is notable that four of these 13 out-licensing companies are frequent fliers in

More from intelligence
Approximately 28 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics